Application of contrast-enhanced ultrasound in the diagnosis of liver solid-cystic lesions
- PMID: 40768959
- DOI: 10.1016/j.ejrad.2025.112336
Application of contrast-enhanced ultrasound in the diagnosis of liver solid-cystic lesions
Abstract
Background: Liver solid-cystic lesions are diverse in type, and accurate differential diagnosis is of great clinical significance. This study aimed retrospectively analyze the sonographic features of conventional ultrasound (US) and contrast-enhanced ultrasound (CEUS) in liver solid-cystic lesions, and to compare their diagnostic performance.
Methods: A total of 157 patients with liver solid-cystic lesions diagnosed by US from January 2011 to November 2024 were retrospectively collected. The clinical features, US and CEUS features of 157 lesions were summarized. The diagnostic performance of CEUS was compared with US and contrast-enhanced computed tomography (CECT) in the evaluation of liver solid-cystic lesions.
Results: This study included 157 lesions comprising 87 benign lesions (37 liver abscesses, 30 hepatic echinococcosis, 8 cysts, and 12 other benign lesions), 8 borderline tumors (5 intraductal papillary neoplasms of the bile duct and 3 mucinous cystic neoplasms), and 62 malignant tumors (24 metastatic carcinomas, 19 hepatocellular carcinomas, 14 intrahepatic cholangiocarcinomas, and 5 other malignant neoplasms).The diagnostic accuracy of US for liver solid-cystic lesions was 64.3 % (95 % confidence interval [CI]: 56.7 %- 72.0 %), while that of CEUS was 84.1 % (95 % CI: 77.9-90.5 %). The difference between the US and CEUS was statistically significant (P<0.001). Comparative analysis of 142 lesions examined with both CEUS and CECT, CEUS showed non-inferior accuracy to CECT (85.2 % [95 % CI: 80.0-90.9 %] vs 81.0 % [95 % CI: 74.7-87.3 %], P = 0.21).
Conclusion: CEUS demonstrates significant promise in the diagnosis of liver solid-cystic lesions. Compared with US, CEUS further enhances diagnostic accuracy and is not inferior to CECT in our study.
Keywords: Contrast-enhanced ultrasound; Diagnosis; Lesion; Liver; Solid-cystic; Ultrasound.
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160. Health Technol Assess. 2013. PMID: 23611316 Free PMC article.
-
Contrast-enhanced US and contrast-enhanced CT for diagnosis of focal liver lesions in liver transplant recipients: A comparative study.ILIVER. 2025 Feb 13;4(1):100147. doi: 10.1016/j.iliver.2025.100147. eCollection 2025 Mar. ILIVER. 2025. PMID: 40636785 Free PMC article.
-
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2. Cochrane Database Syst Rev. 2022. PMID: 36053210 Free PMC article.
-
The application of multimodal ultrasound examination in the differential diagnosis of benign and malignant breast lesions of BI-RADS category 4.Front Med (Lausanne). 2025 Jun 9;12:1596100. doi: 10.3389/fmed.2025.1596100. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40552183 Free PMC article.
-
Can Ultrasound be Used as an Alternative Tool for Pancreatic Cystic Disease Compared With MRI?Asia Pac J Clin Oncol. 2025 Aug;21(4):439-444. doi: 10.1111/ajco.14170. Epub 2025 Apr 13. Asia Pac J Clin Oncol. 2025. PMID: 40223167
LinkOut - more resources
Full Text Sources